Yinjiyue Launches Collector Incense Collection and Scent Guides

Vintage Mysore sandalwood, qinan agarwood and long-burn hinoki join the charcoal-free line, alongside new guides

WUHAN, China – October 19, 2026 – Yinjiyue, a natural Chinese incense brand based in Wuhan, today introduced its collector-grade incense collection and announced a new library of scent guides on its journal, as the brand enters its first full winter season serving households that burn incense for meditation, sleep, and quiet evenings at home.

The collection expansion brings three materials previously unavailable in the brand’s catalog. The first is vintage Mysore sandalwood, cut from 1990s-era oil-rich heartwood sourced from the Mysore core region — the benchmark origin for sandalwood in traditional incense appreciation, offered in a 20-stick collector format alongside the brand’s existing 2019 Classic Mysore line. The second is qinan-grade agarwood in two formats: 9-inch thick sticks of authentic Chinese agarwood, and an ultra-fine 20-stick line detailed as Nha Trang, Vietnam vintage stock. Qinan is the rarest grade of agarwood in Chinese incense culture, softer and sweeter than common oud. The third is Japanese hinoki cypress in a tube of approximately 76 sticks, each burning 40 to 50 minutes — roughly double the burn time of a standard stick — with a ceramic holder included.

All of the brand’s incense is stick-format, coreless and charcoal-free, made without synthetic fragrance oils. The current range covers seven scent families: sandalwood, mugwort, agarwood, pine cone, cliff cypress, hinoki cypress, and white sage, alongside a celadon porcelain holder and a sandalwood essential oil.

Alongside the collection, the brand has launched Yinjiyue Blog, a journal of long-form guides written to help readers choose and use natural incense. The opening guide compares the scent families side by side for readers asking which is the best smelling incense for meditation, sleep, or the home. A second guide profiles the seven herbs most often bound into smudge bundles — white sage, mugwort, cedar, pine, lavender, rosemary, and sweetgrass — tracing where each tradition comes from and how each herb is burned; it is published as herbs for smudge sticks: a tradition-by-tradition introduction. The journal also carries the brand’s mugwort guides, including a practical essay on using mugwort incense for sleep and calmer bedtime rituals, a subject the brand first introduced to its readership in June.

The guides follow a simple editorial method: name the material, name its tradition, describe the scent honestly, and say when to burn it. The scent guide ranks ten product lines against their intended hours — deep meditation against evening wind-down against working hours — while the herbal guide pairs each plant with its cultural origin and a safety-tested burning practice. Both close with sourcing notes, including the distinction between cultivated and wild-harvested white sage, a species under gathering pressure in its native range. Yinjiyue’s white sage bundles are California-grown and cultivated, and the brand says it will not stock wild-harvested material.

The winter release also arrives with the gifting season in view. Incense has quietly become a staple of the “quiet luxury” gift category: modest in price, rich in ritual, and — in Yinjiyue’s case — packaged in the brand’s understated boxes, with the collector formats aimed squarely at recipients who already burn. A starter pairing the brand suggests for gift-givers combines the 2019 Classic Mysore line with the mugwort sticks and the celadon leaf holder, covering the three most common occasions — meditation hours, evenings, and the shelf it all sits on.

“Winter is the season this category was built for — the hours get long, the rooms get small, and people reach for something that makes an evening feel deliberate,” said Rico Smith of Yinjiyue. “The collector grades are for the occasions people actually mark. The guides are for everything else: the ordinary Tuesday when someone just wants to know which stick to light before a book. We would rather teach people to choose well than sell them a sampler they’ll burn half of.”

The timing also reflects a broader shift in home fragrance. Consumers increasingly report treating scent as part of evening wind-down and sensory wellness routines rather than as home decoration, a trend reflected in search interest for herbal and meditation incense over the past two years. Yinjiyue’s charcoal-free formulation produces lighter smoke than traditional bamboo-core incense, a property the brand says matters most to households that burn incense indoors through closed-window months.

The brand’s relationship to mugwort remains its foundation. Known in China as qiai, dried mugwort has been burned in Chinese homes for well over a thousand years — hung at doorways in early summer, rolled into moxa, and made into smoke for the hour before sleep. Yinjiyue’s mugwort line carries that tradition in a modern format, and it remains the most-read subject on the young journal.

“We are a small brand from Wuhan making a very old kind of thing,” Smith added. “Stillness, kept in fragrance — that phrase is on every box we ship, and it is the whole business plan. The collector grades exist because some hours deserve the good wood. The guides exist because the rest of the hours matter too.”

The collector-grade collection and the full charcoal-free range are available now at the brand’s online shop. The scent guides are published weekly at the Yinjiyue Blog.

About Yinjiyue
Yinjiyue is a natural Chinese incense brand based in Wuhan, China. The company makes coreless, charcoal-free incense sticks from natural materials — Mysore sandalwood, mugwort, agarwood, pine cone, cliff cypress, hinoki cypress, and white sage — for meditation, sleep, yoga, and quiet home rituals. The brand’s journal, Yinjiyue Blog, publishes weekly guides on incense materials, scents, and traditions.

More information about Yinjiyue and its collection is available at yinjiyue.com.

Media Contact:
Rico Smith
care@yinjiyue.com
+86 150 7236 5345

Author: Rico Smith, Yinjiyue
Distributed By: Yinjiyue

Disclaimer
This press release is intended for media, brand communication, and general informational purposes only. Product details reflect the brand’s current catalog and may change without notice.

Media Contact:
Name: Rico Smith
Company: Yinjiyue
Email: care@yinjiyue.com
Phone: +86 150 7236 5345
Website: https://yinjiyue.com

REMEVi charges one price at every dose of compounded semaglutide and tirzepatide, with required labs and shipping included

REMEVi newsroom, bilingual GLP-1 telehealth in English and Spanish

REMEVi, a Las Vegas telehealth platform, charges one price at every dose: compounded semaglutide from $159 and tirzepatide from $225 per 4 weeks on its 24-week plan, with care, required labs, supplies and shipping included and no membership fee.

LAS VEGAS — October 15, 2026 — REMEVi, a bilingual telehealth platform for compounded GLP-1 weight-loss medication, charges one price at every dose: compounded semaglutide from $159 per 4 weeks and compounded tirzepatide from $225 per 4 weeks on its 24-week plan. The price includes the clinician evaluation and follow-up, the medication if prescribed, injection or dosing supplies, the GLP-1 lab tests the clinician requires, shipping, and care coordination in English or Spanish. There is no membership fee, and the price does not change when the dose increases or the plan renews.

People comparing GLP-1 programs online tend to ask the same questions before they pay: what the full price is, whether it rises with the dose, which pharmacy prepares the medication, and whether the provider is legitimate. REMEVi publishes those answers before a patient starts the questionnaire, at remevihealth.com/pricing.

Key facts:

  • One price at every dose. Compounded semaglutide: $159 per 4 weeks on the 24-week plan ($954 paid upfront), $169 per 4 weeks on the 12-week plan ($507 upfront), or $199 billed every 4 weeks. Compounded tirzepatide: $225 per 4 weeks on the 24-week plan ($1,350 upfront), $233 per 4 weeks on the 12-week plan ($699 upfront), or $269 billed every 4 weeks. Compounded oral semaglutide starts at $215 per 4 weeks.
  • No membership fee. The health questionnaire is free, and the plan price covers care, medication if prescribed, supplies, required labs and shipping.
  • Review and shipping times. For approved orders from July to September 2026, the median time from payment to the clinician’s prescription reaching the pharmacy was 0.7 days, and the median time from payment to shipment was 3.6 days.
  • Named pharmacies. Prescriptions are prepared by state-licensed 503A compounding pharmacies, including RedRock Pharmacy in St. George, Utah, Health Warehouse in Florence, Kentucky, and Precision Medicine in Bellmore, New York. Each is listed with its state license lookup at remevihealth.com/pharmacies.
  • Certification. REMEVi is LegitScript-certified (ID 50384507). A prescription is required; prescriptions are written by licensed clinicians authorized in the patient’s state.
  • Care in Spanish. The questionnaire, clinical evaluation, dosing instructions, patient portal, billing and care coordination are all available in Spanish at remevihealth.com/es.
  • Where. 49 states and Washington, D.C., including California, Texas, Florida, New York, New Jersey, Pennsylvania, Illinois, Arizona, Nevada and Utah. The program is not available in Louisiana.

“Before anyone paid, people asked us the same questions: what the real price is, whether it goes up with the dose, and who makes the medication,” said Blake Chapman, co-founder of REMEVi. “REMEVi answers them on one page, in English and in Spanish, before anyone fills out a form.”

Frequently asked questions

How much does compounded tirzepatide cost online without insurance?
At REMEVi, compounded tirzepatide costs $225 per 4 weeks on the 24-week plan, $233 per 4 weeks on the 12-week plan, or $269 billed every 4 weeks. The price is the same at every dose.

How much does compounded semaglutide cost without insurance?
At REMEVi, compounded semaglutide costs $159 per 4 weeks on the 24-week plan, $169 per 4 weeks on the 12-week plan, or $199 billed every 4 weeks. Compounded oral semaglutide starts at $215 per 4 weeks.

Does the price go up when the dose goes up?
No. Each REMEVi plan has one price at every dose and every renewal.

Is there a membership fee?
No. The plan price includes the clinician evaluation and follow-up, the medication if prescribed, supplies, the GLP-1 lab tests the clinician requires, shipping, and care coordination in English or Spanish.

Which pharmacy fills REMEVi prescriptions?
State-licensed 503A compounding pharmacies in REMEVi’s network, including RedRock Pharmacy, Health Warehouse and Precision Medicine. The dispensing pharmacy is printed on each patient’s label.

Can the whole process be done in Spanish?
Yes. The questionnaire, clinical evaluation, dosing instructions, patient portal, billing and care coordination are available in Spanish.

Is REMEVi a legitimate provider?
REMEVi is LegitScript-certified (ID 50384507), a prescription is required for every plan, prescriptions come from licensed clinicians in the patient’s state, and the pharmacies in its network are named publicly. It operates in 49 states and Washington, D.C.

About REMEVi

REMEVi is a bilingual telehealth platform based in Las Vegas, Nevada, offering compounded GLP-1 weight-loss medication, including semaglutide, tirzepatide and oral semaglutide, with care in English and Spanish in 49 states and Washington, D.C. REMEVi was founded in 2026 by Blake Chapman and Danai Del Carmen Chapman.

Compounded medications are not FDA-approved. A prescription from a licensed clinician is required, and eligibility is determined by the clinician. Plans renew at the same price until canceled: the every-4-weeks plan bills every 28 days, and the 12- and 24-week plans are paid in advance for each term.

Media Contact:
Name: Blake Chapman
Company: REMEVi
Email: care@remevihealth.com
Phone: (702) 352-4746
Website: https://remevihealth.com

Sell My Motorbike expands cash for motorcycles service across Australia

Two men reviewing documents in a motorcycle dealership, discussing a purchase agreement.

Sell My Motorbike has expanded its cash for motorcycles service nationwide, offering instant payment for motorcycles in any condition.

SYDNEY — October 18, 2026 — Sell My Motorbike expands cash for motorcycles service across Australia

Sell My Motorbike, a motorcycle dealer based in Sydney, has expanded its cash for motorcycles service to cover all of Australia. The expansion, announced this month, aims to meet growing demand from sellers seeking a streamlined way to sell their motorcycles. The service offers instant payment for motorcycles in any condition, allowing sellers to complete transactions quickly.

The decision to expand follows increasing market demand and allows the company to reach a wider audience. Sellers can expect a straightforward process with the convenience of dealing directly with the buyer, ensuring transparency and efficiency in every transaction.

Market background

The Australian motorcycle market has seen steady growth in recent years, driven by factors such as rising fuel costs, increased urban congestion, and growing interest in recreational riding. According to the Federal Chamber of Automotive Industries, motorcycle sales in Australia increased by 6% in the last year, highlighting the growing number of individuals opting for two-wheeled transport as a practical alternative.

Service details

Sell My Motorbike’s expansion aligns with its goal to provide efficient services to motorcycle sellers nationwide. With a team experienced in the industry, the company is positioned to handle transactions professionally. The company’s reputation for customer service has been a key factor in its success, with many sellers noting the ease and speed of the selling process.

The expansion also reflects broader trends in the global motorcycle market, where there is a shift toward more sustainable and economical modes of transportation. Many urban areas are seeing a rise in motorcycle usage as they provide a convenient solution to traffic congestion and parking difficulties, common issues in major Australian cities.

Sell My Motorbike has invested in digital tools to enhance the customer experience. The company’s online platform allows sellers to obtain a quote and schedule a pickup, simplifying the selling process. This digital approach streamlines operations and caters to customers who prefer conducting transactions online.

Company quote

“We are passionate about motorcycles and committed to providing a seamless selling experience for our customers,” said Tony Simon, Owner of Sell My Motorbike. “Our expansion across Australia allows us to offer our expertise and services to more motorcycle sellers who are looking for a hassle-free way to sell their bikes.”

About Sell My Motorbike

Sell My Motorbike is an Australian motorcycle dealer with over 30 years of industry experience. The company’s owner, Tony Simon, brings extensive knowledge to the business. The motorcycle buying team takes pride in its work and strives to exceed customer expectations. The company’s commitment to transparency and customer satisfaction has earned it a loyal customer base and a trusted reputation across the industry.

Media Contact:
Name: Tony Simon
Company: Sell My Motorbike
Email: tonysimonwork@gmail.com
Phone: 0493 825 076
Address: 22 Belgrave St Kogarah NSW 2217
Website: https://sellmymotorbike.com.au/

ViralGreece.gr highlights its editorial coverage of Greek news and global trends

ViralGreece.gr highlights its editorial coverage of Greek news and global trends

ViralGreece.gr, a Greek digital news platform, provides coverage of breaking news, technology, business, entertainment, and trending stories from Greece and around the world.

ATHENS, GR — October 17, 2026 — ViralGreece.gr highlights its editorial coverage of Greek news and global trends

ViralGreece.gr, a Greek-language digital news platform, is highlighting its editorial coverage of current affairs, technology, business, entertainment, and trending stories. The publication brings together news from Greece and around the world, providing readers with access to a broad range of topics through a single online destination.

As digital news consumption continues to shape how audiences discover and follow events, independent online publications play an important role in making information accessible to different communities.

A digital destination for Greek news and current affairs

ViralGreece.gr covers developments across several editorial categories, including Greek news, international affairs, society, economics, technology, and entertainment.

Its coverage is intended for readers who want to stay informed about current events while also exploring the stories, developments, and conversations attracting attention across digital platforms.

By combining traditional news subjects with internet trends, the website offers an editorial mix that reflects the different interests of contemporary online audiences.

Technology, business and digital culture

Technology has become an increasingly important part of everyday life, influencing how people communicate, work, consume information, and interact with businesses.

Viral Greece covers developments in technology and digital culture alongside economic news and topics affecting consumers, companies, and society.

The publication also features stories about online platforms, social media developments, entertainment, and emerging trends.

This combination allows readers to explore both major news events and the digital developments influencing public conversations.

Editorial transparency and responsible publishing

Transparency is an important consideration for readers choosing where to obtain information online.

ViralGreece.gr publicly identifies members of its editorial team and provides information about its publishing responsibilities and correction procedures.

According to the publication’s editorial information, articles undergo human review before publication. Readers can also contact the website to report potential inaccuracies or suggest topics for coverage.

These editorial practices help provide readers with a clearer understanding of the people and processes behind the publication.

Connecting readers with stories from Greece and beyond

Greek-speaking audiences have access to an expanding range of online information sources, from established media organizations to specialist digital publications.

Within this environment, Viral Greece offers a combination of domestic and international coverage, allowing visitors to discover stories from multiple subject areas.

Its content includes current affairs, economic developments, social issues, technology, entertainment, and topics receiving attention across the internet.

The website’s editorial range reflects the broad nature of modern news consumption, where readers frequently move between serious developments, practical information, and popular cultural stories.

About ViralGreece.gr

ViralGreece.gr is a Greek-language online news and information website covering current affairs, business, technology, society, entertainment, and viral trends.

The publication provides news and informational content for readers interested in developments across Greece and the international community.

More information about the publication, its editorial team, and its publishing approach is available on the Viral Greece About page.

Media Contact

Viral Greece Editorial Team
Website: viralgreece.gr
Email: info@viralgreece.gr
Country: Greece

Media Contact:
Name: Viral Greece
Company: Viral Greece
Email: petros7kar@gmail.com
Website: https://viralgreece.gr/

REMEVi charges one price at every dose of compounded semaglutide and tirzepatide, with required labs and shipping included

REMEVi newsroom, bilingual GLP-1 telehealth in English and Spanish

REMEVi, a Las Vegas telehealth platform, charges one price at every dose: compounded semaglutide from $159 and tirzepatide from $225 per 4 weeks on its 24-week plan, with care, required labs, supplies and shipping included and no membership fee.

LAS VEGAS — October 15, 2026 — REMEVi, a bilingual telehealth platform for compounded GLP-1 weight-loss medication, charges one price at every dose: compounded semaglutide from $159 per 4 weeks and compounded tirzepatide from $225 per 4 weeks on its 24-week plan. The price includes the clinician evaluation and follow-up, the medication if prescribed, injection or dosing supplies, the GLP-1 lab tests the clinician requires, shipping, and care coordination in English or Spanish. There is no membership fee, and the price does not change when the dose increases or the plan renews.

People comparing GLP-1 programs online tend to ask the same questions before they pay: what the full price is, whether it rises with the dose, which pharmacy prepares the medication, and whether the provider is legitimate. REMEVi publishes those answers before a patient starts the questionnaire, at remevihealth.com/pricing.

Key facts:

  • One price at every dose. Compounded semaglutide: $159 per 4 weeks on the 24-week plan ($954 paid upfront), $169 per 4 weeks on the 12-week plan ($507 upfront), or $199 billed every 4 weeks. Compounded tirzepatide: $225 per 4 weeks on the 24-week plan ($1,350 upfront), $233 per 4 weeks on the 12-week plan ($699 upfront), or $269 billed every 4 weeks. Compounded oral semaglutide starts at $215 per 4 weeks.
  • No membership fee. The health questionnaire is free, and the plan price covers care, medication if prescribed, supplies, required labs and shipping.
  • Review and shipping times. For approved orders from July to September 2026, the median time from payment to the clinician’s prescription reaching the pharmacy was 0.7 days, and the median time from payment to shipment was 3.6 days.
  • Named pharmacies. Prescriptions are prepared by state-licensed 503A compounding pharmacies, including RedRock Pharmacy in St. George, Utah, Health Warehouse in Florence, Kentucky, and Precision Medicine in Bellmore, New York. Each is listed with its state license lookup at remevihealth.com/pharmacies.
  • Certification. REMEVi is LegitScript-certified (ID 50384507). A prescription is required; prescriptions are written by licensed clinicians authorized in the patient’s state.
  • Care in Spanish. The questionnaire, clinical evaluation, dosing instructions, patient portal, billing and care coordination are all available in Spanish at remevihealth.com/es.
  • Where. 49 states and Washington, D.C., including California, Texas, Florida, New York, New Jersey, Pennsylvania, Illinois, Arizona, Nevada and Utah. The program is not available in Louisiana.

“Before anyone paid, people asked us the same questions: what the real price is, whether it goes up with the dose, and who makes the medication,” said Blake Chapman, co-founder of REMEVi. “REMEVi answers them on one page, in English and in Spanish, before anyone fills out a form.”

Frequently asked questions

How much does compounded tirzepatide cost online without insurance?
At REMEVi, compounded tirzepatide costs $225 per 4 weeks on the 24-week plan, $233 per 4 weeks on the 12-week plan, or $269 billed every 4 weeks. The price is the same at every dose.

How much does compounded semaglutide cost without insurance?
At REMEVi, compounded semaglutide costs $159 per 4 weeks on the 24-week plan, $169 per 4 weeks on the 12-week plan, or $199 billed every 4 weeks. Compounded oral semaglutide starts at $215 per 4 weeks.

Does the price go up when the dose goes up?
No. Each REMEVi plan has one price at every dose and every renewal.

Is there a membership fee?
No. The plan price includes the clinician evaluation and follow-up, the medication if prescribed, supplies, the GLP-1 lab tests the clinician requires, shipping, and care coordination in English or Spanish.

Which pharmacy fills REMEVi prescriptions?
State-licensed 503A compounding pharmacies in REMEVi’s network, including RedRock Pharmacy, Health Warehouse and Precision Medicine. The dispensing pharmacy is printed on each patient’s label.

Can the whole process be done in Spanish?
Yes. The questionnaire, clinical evaluation, dosing instructions, patient portal, billing and care coordination are available in Spanish.

Is REMEVi a legitimate provider?
REMEVi is LegitScript-certified (ID 50384507), a prescription is required for every plan, prescriptions come from licensed clinicians in the patient’s state, and the pharmacies in its network are named publicly. It operates in 49 states and Washington, D.C.

About REMEVi

REMEVi is a bilingual telehealth platform based in Las Vegas, Nevada, offering compounded GLP-1 weight-loss medication, including semaglutide, tirzepatide and oral semaglutide, with care in English and Spanish in 49 states and Washington, D.C. REMEVi was founded in 2026 by Blake Chapman and Danai Del Carmen Chapman.

Compounded medications are not FDA-approved. A prescription from a licensed clinician is required, and eligibility is determined by the clinician. Plans renew at the same price until canceled: the every-4-weeks plan bills every 28 days, and the 12- and 24-week plans are paid in advance for each term.

Media Contact:
Name: Blake Chapman
Company: REMEVi
Email: care@remevihealth.com
Phone: (702) 352-4746
Website: https://remevihealth.com

REMEVi charges one price at every dose of compounded semaglutide and tirzepatide, with required labs and shipping included

REMEVi newsroom, bilingual GLP-1 telehealth in English and Spanish

REMEVi, a Las Vegas telehealth platform, charges one price at every dose: compounded semaglutide from $159 and tirzepatide from $225 per 4 weeks on its 24-week plan, with care, required labs, supplies and shipping included and no membership fee.

LAS VEGAS — October 15, 2026 — REMEVi, a bilingual telehealth platform for compounded GLP-1 weight-loss medication, charges one price at every dose: compounded semaglutide from $159 per 4 weeks and compounded tirzepatide from $225 per 4 weeks on its 24-week plan. The price includes the clinician evaluation and follow-up, the medication if prescribed, injection or dosing supplies, the GLP-1 lab tests the clinician requires, shipping, and care coordination in English or Spanish. There is no membership fee, and the price does not change when the dose increases or the plan renews.

People comparing GLP-1 programs online tend to ask the same questions before they pay: what the full price is, whether it rises with the dose, which pharmacy prepares the medication, and whether the provider is legitimate. REMEVi publishes those answers before a patient starts the questionnaire, at remevihealth.com/pricing.

Key facts:

  • One price at every dose. Compounded semaglutide: $159 per 4 weeks on the 24-week plan ($954 paid upfront), $169 per 4 weeks on the 12-week plan ($507 upfront), or $199 billed every 4 weeks. Compounded tirzepatide: $225 per 4 weeks on the 24-week plan ($1,350 upfront), $233 per 4 weeks on the 12-week plan ($699 upfront), or $269 billed every 4 weeks. Compounded oral semaglutide starts at $215 per 4 weeks.
  • No membership fee. The health questionnaire is free, and the plan price covers care, medication if prescribed, supplies, required labs and shipping.
  • Review and shipping times. For approved orders from July to September 2026, the median time from payment to the clinician’s prescription reaching the pharmacy was 0.7 days, and the median time from payment to shipment was 3.6 days.
  • Named pharmacies. Prescriptions are prepared by state-licensed 503A compounding pharmacies, including RedRock Pharmacy in St. George, Utah, Health Warehouse in Florence, Kentucky, and Precision Medicine in Bellmore, New York. Each is listed with its state license lookup at remevihealth.com/pharmacies.
  • Certification. REMEVi is LegitScript-certified (ID 50384507). A prescription is required; prescriptions are written by licensed clinicians authorized in the patient’s state.
  • Care in Spanish. The questionnaire, clinical evaluation, dosing instructions, patient portal, billing and care coordination are all available in Spanish at remevihealth.com/es.
  • Where. 49 states and Washington, D.C., including California, Texas, Florida, New York, New Jersey, Pennsylvania, Illinois, Arizona, Nevada and Utah. The program is not available in Louisiana.

“Before anyone paid, people asked us the same questions: what the real price is, whether it goes up with the dose, and who makes the medication,” said Blake Chapman, co-founder of REMEVi. “REMEVi answers them on one page, in English and in Spanish, before anyone fills out a form.”

Frequently asked questions

How much does compounded tirzepatide cost online without insurance?
At REMEVi, compounded tirzepatide costs $225 per 4 weeks on the 24-week plan, $233 per 4 weeks on the 12-week plan, or $269 billed every 4 weeks. The price is the same at every dose.

How much does compounded semaglutide cost without insurance?
At REMEVi, compounded semaglutide costs $159 per 4 weeks on the 24-week plan, $169 per 4 weeks on the 12-week plan, or $199 billed every 4 weeks. Compounded oral semaglutide starts at $215 per 4 weeks.

Does the price go up when the dose goes up?
No. Each REMEVi plan has one price at every dose and every renewal.

Is there a membership fee?
No. The plan price includes the clinician evaluation and follow-up, the medication if prescribed, supplies, the GLP-1 lab tests the clinician requires, shipping, and care coordination in English or Spanish.

Which pharmacy fills REMEVi prescriptions?
State-licensed 503A compounding pharmacies in REMEVi’s network, including RedRock Pharmacy, Health Warehouse and Precision Medicine. The dispensing pharmacy is printed on each patient’s label.

Can the whole process be done in Spanish?
Yes. The questionnaire, clinical evaluation, dosing instructions, patient portal, billing and care coordination are available in Spanish.

Is REMEVi a legitimate provider?
REMEVi is LegitScript-certified (ID 50384507), a prescription is required for every plan, prescriptions come from licensed clinicians in the patient’s state, and the pharmacies in its network are named publicly. It operates in 49 states and Washington, D.C.

About REMEVi

REMEVi is a bilingual telehealth platform based in Las Vegas, Nevada, offering compounded GLP-1 weight-loss medication, including semaglutide, tirzepatide and oral semaglutide, with care in English and Spanish in 49 states and Washington, D.C. REMEVi was founded in 2026 by Blake Chapman and Danai Del Carmen Chapman.

Compounded medications are not FDA-approved. A prescription from a licensed clinician is required, and eligibility is determined by the clinician. Plans renew at the same price until canceled: the every-4-weeks plan bills every 28 days, and the 12- and 24-week plans are paid in advance for each term.

Media Contact:
Name: Blake Chapman
Company: REMEVi
Email: care@remevihealth.com
Phone: (702) 352-4746
Website: https://remevihealth.com

Maureen Martin at HomePlus Mortgage Helps San Diego County VA Borrowers Navigate VA Home Purchases, VA Refinances and VA IRRRLs

Maureen Martin of HomePlus Mortgage smiling with arms crossed, wearing a dark pinstripe blazer and blue top

With more than 26+ years of experience, Maureen Martin helps San Diego County borrowers compare VA, reverse mortgage, purchase, second mortgages and refinance options.

SAN DIEGO — October 13, 2026 — Maureen Martin at HomePlus Mortgage, a San Diego mortgage broker, specializes in VA home loans across San Diego County. She helps eligible veterans, active-duty service members and qualifying surviving spouses compare San Diego VA home loans for home purchases and refinances, including VA Interest Rate Reduction Refinance Loans (IRRRLs).

Maureen Martin at HomePlus Mortgage compares loan programs through a wide array of wholesale lenders.

VA Purchases, VA Refinances and VA IRRRLs

A San Diego VA loan may allow eligible borrowers with full entitlement to purchase with no down payment and no monthly private mortgage insurance (PMI). Requirements apply: borrowers must establish eligibility and meet credit, income and property standards, and closing costs and a VA funding fee typically apply unless the borrower is exempt.

VA refinance options include:

  1. VA IRRRL: a VA-to-VA refinance that does not take cash out. It may help lower an interest rate or convert an adjustable rate to a fixed rate. IRRRLs must meet VA seasoning, recoupment and net tangible benefit requirements.

  2. VA cash-out refinance: a refinance that may let eligible homeowners access equity for home improvements or debt consolidation, subject to VA and lender requirements.

“San Diego has a large military community, and many VA borrowers don’t know every option their benefit offers,” said Maureen Martin. “My job is to explain the choices in plain language, compare programs, and help each borrower decide what makes sense for them.”

Full Range of San Diego Mortgage Services

  1. Beyond VA financing, Maureen Martin offers:

  2. Home purchase loans for first-time and move-up buyers

  3. Conventional and FHA loans

  4. Rate-and-term and cash-out refinancing

  5. Debt consolidation loans also known as HELOCs or second mortgages for homeowners who may want to access available equity while keeping an existing low-rate first mortgage in place.

  6. Reverse mortgages, including HECMs for eligible homeowners age 62 and older, as well as proprietary reverse mortgage options that may be available to eligible borrowers as young as age 55. For HECMs, no monthly principal and interest payment is generally required, but borrowers must continue to pay property taxes and homeowners insurance, maintain the home and meet other loan obligations. The home must be the primary residence, HUD-approved counseling is required, and the loan balance generally grows over time. Proprietary reverse mortgage program requirements vary by lender and product.


Mortgage Broker Serving San Diego County

Maureen Martin works with borrowers throughout San Diego County, including San Diego, University City, University Heights, North Park, South Park, Normal Heights, Clairemont, Bay Park, Serra Mesa, Linda Vista, Mission Valley, Mira Mesa, Tierrasanta, Kearny Mesa, Allied Gardens, San Carlos, Del Cerro, Pacific Beach, Ocean Beach, Otay Mesa, La Mesa, Lemon Grove, El Cajon, Santee, Spring Valley, Lakeside, Rancho San Diego, Chula Vista, Imperial Beach, Bonita, Oceanside, Carlsbad, Vista, San Marcos, Escondido, Fallbrook and Ramona.

Quick Answers

What is a VA IRRRL? A VA Interest Rate Reduction Refinance Loan refinances an existing VA loan into a new VA loan without taking cash out.

Why use an independent mortgage broker for a VA loan? Maureen Martin at HomePlus Mortgage, a San Diego mortgage broker, can compare VA loan options from a wide array of wholesale lenders.

Can a VA loan be used more than once? Often, yes. Depending on remaining entitlement, or whether entitlement from a prior VA loan has been restored, eligible borrowers may be able to use their VA home loan benefit again. Program requirements still apply.

About Maureen Martin at HomePlus Mortgage

Maureen Martin at HomePlus Mortgage is a San Diego mortgage broker who has served the San Diego mortgage market since 1999. With more than 26+ years of experience and access to a wide array of wholesale lenders, she focuses on VA purchases, VA refinances and VA IRRRLs, as well as reverse mortgages, including HECMs for eligible homeowners age 62 and older and proprietary reverse mortgage options that may be available to eligible borrowers as young as age 55. She also helps first-time homebuyers, move-up and repeat buyers, and buyers relocating to San Diego. Her services include conventional, FHA, jumbo and high-balance loans; first-mortgage refinances, including those tied to divorce, estate settlements or co-owner buyouts; debt consolidation loans and second mortgages; and non-QM options such as bank statement loans for purchases and refinances. Borrowers searching for a mortgage lender near me can learn more at sandiegohomelender.com.

Maureen Martin | NMLS #247664 | DRE #01266511 — HomePlus Corporation dba HomePlus Mortgage dba SanDiegoHomeLender NMLS 78669 | DRE 01426454. NMLS Consumer Access: www.nmlsconsumeraccess.org. HomePlus Mortgage is not affiliated with the VA, FHA, HUD or any other government agency. All loans are subject to borrower eligibility, credit approval, underwriting and property requirements. Program terms and availability may change. Equal Housing Opportunity.

View on Google Maps

Media Contact:
Name: Maureen Martin
Company: Maureen Martin at HomePlus Mortgage
Email: maureen@mylifelender.com
Phone: (619) 857-7191
Address: 1455 Frazee Rd Ste 500, San Diego, CA 92108
Website: https://sandiegohomelender.com/

REMEVi charges one price at every dose of compounded semaglutide and tirzepatide, with required labs and shipping included

REMEVi newsroom, bilingual GLP-1 telehealth in English and Spanish

REMEVi, a Las Vegas telehealth platform, charges one price at every dose: compounded semaglutide from $159 and tirzepatide from $225 per 4 weeks on its 24-week plan, with care, required labs, supplies and shipping included and no membership fee.

LAS VEGAS — October 15, 2026 — REMEVi, a bilingual telehealth platform for compounded GLP-1 weight-loss medication, charges one price at every dose: compounded semaglutide from $159 per 4 weeks and compounded tirzepatide from $225 per 4 weeks on its 24-week plan. The price includes the clinician evaluation and follow-up, the medication if prescribed, injection or dosing supplies, the GLP-1 lab tests the clinician requires, shipping, and care coordination in English or Spanish. There is no membership fee, and the price does not change when the dose increases or the plan renews.

People comparing GLP-1 programs online tend to ask the same questions before they pay: what the full price is, whether it rises with the dose, which pharmacy prepares the medication, and whether the provider is legitimate. REMEVi publishes those answers before a patient starts the questionnaire, at remevihealth.com/pricing.

Key facts:

  • One price at every dose. Compounded semaglutide: $159 per 4 weeks on the 24-week plan ($954 paid upfront), $169 per 4 weeks on the 12-week plan ($507 upfront), or $199 billed every 4 weeks. Compounded tirzepatide: $225 per 4 weeks on the 24-week plan ($1,350 upfront), $233 per 4 weeks on the 12-week plan ($699 upfront), or $269 billed every 4 weeks. Compounded oral semaglutide starts at $215 per 4 weeks.
  • No membership fee. The health questionnaire is free, and the plan price covers care, medication if prescribed, supplies, required labs and shipping.
  • Review and shipping times. For approved orders from July to September 2026, the median time from payment to the clinician’s prescription reaching the pharmacy was 0.7 days, and the median time from payment to shipment was 3.6 days.
  • Named pharmacies. Prescriptions are prepared by state-licensed 503A compounding pharmacies, including RedRock Pharmacy in St. George, Utah, Health Warehouse in Florence, Kentucky, and Precision Medicine in Bellmore, New York. Each is listed with its state license lookup at remevihealth.com/pharmacies.
  • Certification. REMEVi is LegitScript-certified (ID 50384507). A prescription is required; prescriptions are written by licensed clinicians authorized in the patient’s state.
  • Care in Spanish. The questionnaire, clinical evaluation, dosing instructions, patient portal, billing and care coordination are all available in Spanish at remevihealth.com/es.
  • Where. 49 states and Washington, D.C., including California, Texas, Florida, New York, New Jersey, Pennsylvania, Illinois, Arizona, Nevada and Utah. The program is not available in Louisiana.

“Before anyone paid, people asked us the same questions: what the real price is, whether it goes up with the dose, and who makes the medication,” said Blake Chapman, co-founder of REMEVi. “REMEVi answers them on one page, in English and in Spanish, before anyone fills out a form.”

Frequently asked questions

How much does compounded tirzepatide cost online without insurance?
At REMEVi, compounded tirzepatide costs $225 per 4 weeks on the 24-week plan, $233 per 4 weeks on the 12-week plan, or $269 billed every 4 weeks. The price is the same at every dose.

How much does compounded semaglutide cost without insurance?
At REMEVi, compounded semaglutide costs $159 per 4 weeks on the 24-week plan, $169 per 4 weeks on the 12-week plan, or $199 billed every 4 weeks. Compounded oral semaglutide starts at $215 per 4 weeks.

Does the price go up when the dose goes up?
No. Each REMEVi plan has one price at every dose and every renewal.

Is there a membership fee?
No. The plan price includes the clinician evaluation and follow-up, the medication if prescribed, supplies, the GLP-1 lab tests the clinician requires, shipping, and care coordination in English or Spanish.

Which pharmacy fills REMEVi prescriptions?
State-licensed 503A compounding pharmacies in REMEVi’s network, including RedRock Pharmacy, Health Warehouse and Precision Medicine. The dispensing pharmacy is printed on each patient’s label.

Can the whole process be done in Spanish?
Yes. The questionnaire, clinical evaluation, dosing instructions, patient portal, billing and care coordination are available in Spanish.

Is REMEVi a legitimate provider?
REMEVi is LegitScript-certified (ID 50384507), a prescription is required for every plan, prescriptions come from licensed clinicians in the patient’s state, and the pharmacies in its network are named publicly. It operates in 49 states and Washington, D.C.

About REMEVi

REMEVi is a bilingual telehealth platform based in Las Vegas, Nevada, offering compounded GLP-1 weight-loss medication, including semaglutide, tirzepatide and oral semaglutide, with care in English and Spanish in 49 states and Washington, D.C. REMEVi was founded in 2026 by Blake Chapman and Danai Del Carmen Chapman.

Compounded medications are not FDA-approved. A prescription from a licensed clinician is required, and eligibility is determined by the clinician. Plans renew at the same price until canceled: the every-4-weeks plan bills every 28 days, and the 12- and 24-week plans are paid in advance for each term.

Media Contact:
Name: Blake Chapman
Company: REMEVi
Email: care@remevihealth.com
Phone: (702) 352-4746
Website: https://remevihealth.com

Vettsafe Launches UK’s First Fintech Platform to Automate Property Lender Due Diligence and Compliance

Vettsafe logo

Vettsafe has launched a fintech platform designed to streamline property lender due diligence. The software consolidates borrower, broker, solicitor and company background checks into a single automated workflow, with automatic capture of timestamped supporting evidence for case files.

LONDON, United Kingdom, Oct. 12, 2026 — Vettsafe has launched what the company describes as the UK’s first lender fintech platform, designed to consolidate four core due diligence checks into a single automated workflow for property lenders, legal departments, underwriters and compliance teams.

The platform brings together searches relating to borrowers, brokers, solicitors and companies. It is designed to help lending teams manage background checks through a central dashboard while automatically capturing timestamped supporting evidence for individual credit and case files.

Property lending teams traditionally conduct property lender due diligence across multiple external registers, regulatory databases and websites. This process can require staff to search separate sources, review findings individually and save screenshots manually to document their work. Vettsafe brings these activities into one workflow, with the aim of helping teams organize research and maintain supporting documentation more efficiently.

When a user enters transaction details, the system runs applicable searches simultaneously, presents the results in a central dashboard and archives supporting digital evidence. The approach is intended to reduce administrative work associated with underwriting and case reviews.

The platform covers four main areas of due diligence:

  • Borrower checks: Reviews regulatory and personal background information on individuals seeking property finance.

  • Broker checks: Examines firm credentials, intermediary details and regulatory status for introducers.

  • Solicitor checks: Reviews professional qualifications and firm standing for legal representatives involved in transactions.

  • Company checks: Brings together corporate records, financial filings and officer details for business entities.

By presenting findings in a consolidated view, the platform is designed to help lending teams identify discrepancies and potential fraud indicators earlier in the credit assessment process.

A central feature is automated evidence capture. The software records timestamped screenshots of supporting search results and compiles the documentation into the relevant case file. This provides a record of the information available at the time of a decision and supports audit and compliance processes.

The platform is intended to support professional decision-making across legal, underwriting and compliance teams, while helping users organize information and progress cases more efficiently.

“Property lenders carry out critical due-diligence checks every single day, but those processes have historically been scattered across different websites,” said Kamil Mughal, founder and real estate consultant at Vettsafe. “Vettsafe brings four essential searches into one workflow, automatically capturing supporting evidence so lending teams can operate with total clarity, identify early fraud signals, and maintain a clear, defensible audit trail for every transaction.”

About Vettsafe

Vettsafe is a UK-based fintech company providing due diligence technology for specialist finance, bridging and commercial property lenders. Its platform brings multiple searches into a single workflow to help legal, underwriting and compliance teams organize checks, document findings and identify potential transaction risks earlier in the lending process.

For more information, visit https://www.vettsafe.com.

Media Contact:
Name: Kamil Mughal
Company: Vettsafe
Email: Contact@vettsafe.com
Phone: +44 07424298239
Address: 20, Km Global Capital First Floor, Swan Buildings, Swan Street, Manchester, United Kingdom, M4 5JW
Website: https://www.vettsafe.com/

NewsCrypto Launches Real-Time Crypto Market News Platform

NewsCrypto Launches Real-Time Crypto Market News Platform

Newscrypto.org has positioned itself as a key player in delivering fast and reliable crypto news. The platform offers up-to-date information on cryptocurrency trends and market insights.

LONDON, United Kingdom — — NewsCrypto today announced the launch of its real-time cryptocurrency and digital-markets news platform, providing concise updates, market context and coverage of developments across Bitcoin, Ethereum, digital assets, blockchain infrastructure and the wider financial-markets landscape.

The platform is designed for readers seeking timely, accessible reporting during a period of continued change across the digital-asset industry. NewsCrypto publishes breaking-news updates alongside explainers and market context intended to help readers understand the events shaping the sector.

As adoption of digital assets and blockchain technology continues to develop globally, demand has grown for reliable, easy-to-understand information. NewsCrypto responds to this need by combining breaking-news updates with explanatory articles, market-focused reporting and coverage of developments relevant to both newcomers and experienced participants in the crypto ecosystem.

“Digital-asset markets move quickly, and readers need timely information presented in a clear and responsible way,” said Martin Soverski at NewsCrypto. “Our goal is to make important developments easier to follow by delivering concise coverage and useful context across the stories shaping this industry.”

NewsCrypto’s launch includes live market pages, topic hubs, mobile alerts, multilingual coverage. The company plans to expand its coverage based on reader demand and developments across the digital-asset ecosystem.

NewsCrypto is available at https://newscrypto.org.

About NewsCrypto

NewsCrypto is a digital news platform covering cryptocurrency, blockchain technology and financial-market developments. The platform publishes real-time updates, market context and explanatory reporting for an international audience interested in the evolving digital-asset economy.

Media contact
Joe Sanderson
Director
Newscrypto.org
support@newscrypto.org
newscrypto.org

Media Contact:
Name: Joe Sanderson
Company: News Crypto
Email: alfidehamirali@gmail.com
Website: https://newscrypto.org/